Correlation Between Hanover Insurance and CERo Therapeutics

Can any of the company-specific risk be diversified away by investing in both Hanover Insurance and CERo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hanover Insurance and CERo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between The Hanover Insurance and CERo Therapeutics Holdings,, you can compare the effects of market volatilities on Hanover Insurance and CERo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hanover Insurance with a short position of CERo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hanover Insurance and CERo Therapeutics.

Diversification Opportunities for Hanover Insurance and CERo Therapeutics

0.78

Correlation Coefficient

Hanover Insurance  CERo Therapeutics

Poor diversification

The 3 months correlation between Hanover and CERo is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding The Hanover Insurance and CERo Therapeutics Holdings, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CERo Therapeutics and Hanover Insurance is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on The Hanover Insurance are associated (or correlated) with CERo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CERo Therapeutics has no effect on the direction of Hanover Insurance i.e., Hanover Insurance and CERo Therapeutics go up and down completely randomly.

Pair Corralation between Hanover Insurance and CERo Therapeutics

Considering the 90-day investment horizon Hanover Insurance is expected to generate 17.23 times less return on investment than CERo Therapeutics. But when comparing it to its historical volatility, The Hanover Insurance is 20.85 times less risky than CERo Therapeutics. It trades about 0.06 of its potential returns per unit of risk. CERo Therapeutics Holdings, is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  8.40  in CERo Therapeutics Holdings, on September 17, 2024 and sell it today you would lose (3.30) from holding CERo Therapeutics Holdings, or give up 39.29% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

The Hanover Insurance  vs.  CERo Therapeutics Holdings,

Hanover Insurance

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in The Hanover Insurance are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable technical indicators, Hanover Insurance is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

CERo Therapeutics

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in CERo Therapeutics Holdings, are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very abnormal basic indicators, CERo Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Hanover Insurance and CERo Therapeutics

The main advantage of trading using opposite Hanover Insurance and CERo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hanover Insurance position performs unexpectedly, CERo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CERo Therapeutics will offset losses from the drop in CERo Therapeutics' long position.

The idea behind The Hanover Insurance and CERo Therapeutics Holdings, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.